October 30, 2020 Go or no go? Big decisions loom for Bristol and Sanofi The FDA will have a busy November, with decisions due for Bristol, Sanofi and Y-mabs, among others.
June 26, 2019 Botox and the value of never-ending profits Abbvie’s bid for Allergan shows that the Botox franchise is impenetrable. The market agrees.